NCT04260282View on ClinicalTrials.gov

Microbiome and Exacerbations in Neutrophilic Asthma

UnknownOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2025

Conditions
AsthmaMicrobiomeExacerbation
Interventions
DIAGNOSTIC_TEST

Polymerase Chain Reaction (PCR) for viruses and bacteria in nasal swab

PCR for viruses and bacteria in nasal swab

DIAGNOSTIC_TEST

Induced sputum microbiome

Microbiome in induced sputum

Trial Locations (1)

08041

RECRUITING

Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90., Barcelona

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

Sociedad Española de Neumología y Cirugía Torácica

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT04260282 - Microbiome and Exacerbations in Neutrophilic Asthma | Biotech Hunter | Biotech Hunter